Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells.

Literature DB >> 4292975

Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells.

P Gerber, S M Birch.

Abstract

Entities: Disease Species

Mesh：

Substances：
Immune Sera

Year: 1967 PMID： 4292975 PMCID： PMC335660 DOI： 10.1073/pnas.58.2.478

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

16 in total

1. SYRIAN HAMSTER FIBROBLAST CELL LINE BHK21 AND ITS DERIVATIVES.

Authors: M STOKER; I MACPHERSON
Journal: Nature Date: 1964-09-26 Impact factor: 49.962

2. BURKITT TUMOR: TISSUE CULTURE, CYTOGENETIC AND VIRUS STUDIES.

Authors: S E STEWART; E LOVELACE; J J WHANG; V A NGU
Journal: J Natl Cancer Inst Date: 1965-02 Impact factor: 13.506

3. Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition.

Authors: E WASSERMAN; L LEVINE
Journal: J Immunol Date: 1961-09 Impact factor: 5.422

4. Amino acid requirements of the Novikoff hepatoma in vitro.

Authors: T A McCOY; M MAXWELL; P F KRUSE
Journal: Proc Soc Exp Biol Med Date: 1959-01

5. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

Authors: L J Old; E A Boyse; H F Oettgen; E D Harven; G Geering; B Williamson; P Clifford
Journal: Proc Natl Acad Sci U S A Date: 1966-12 Impact factor: 11.205

6. Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors: G Henle; W Henle
Journal: J Bacteriol Date: 1966-03 Impact factor: 3.490

7. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors: M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal: J Natl Cancer Inst Date: 1966-10 Impact factor: 13.506

8. Culture of normal human leukocytes.

Authors: G E Moore; R E Gerner; H A Franklin
Journal: JAMA Date: 1967-02-20 Impact factor: 56.272

9. Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells.

Authors: W Henle; K Hummeler; G Henle
Journal: J Bacteriol Date: 1966-07 Impact factor: 3.490

10. Partial purification and electron microscopy of virus in the EB-3 cell line derived from a Burkitt lymphoma.

Authors: I Toplin; G Schidlovsky
Journal: Science Date: 1966-05-20 Impact factor: 47.728

25 in total

1. Host responses to Epstein-Barr virus and cytomegalovirus infection in leprosy.

Authors: P S Papageorgiou; C F Sorokin; K Kouzoutzakoglou; R J Bonforte; P L Workman; P R Glade
Journal: Infect Immun Date: 1973-04 Impact factor: 3.441

2. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors: G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal: Proc Natl Acad Sci U S A Date: 1972-02 Impact factor: 11.205

10. Viruses detected in cells explanted into tissue culture from naturally occurring malignant lymphoma in rhesus monkeys.

Authors: J S Manning; R A Griesemer
Journal: Curr Microbiol Date: 1978 Impact factor: 2.188

Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells.

1. SYRIAN HAMSTER FIBROBLAST CELL LINE BHK21 AND ITS DERIVATIVES.

2. BURKITT TUMOR: TISSUE CULTURE, CYTOGENETIC AND VIRUS STUDIES.

3. Quantitative micro-complement fixation and its use in the study of antigenic structure by specific antigen-antibody inhibition.

4. Amino acid requirements of the Novikoff hepatoma in vitro.

5. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

6. Immunofluorescence in cells derived from Burkitt's lymphoma.

7. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

8. Culture of normal human leukocytes.

9. Antibody coating and agglutination of virus particles separated from the EB3 line of Burkitt lymphoma cells.

10. Partial purification and electron microscopy of virus in the EB-3 cell line derived from a Burkitt lymphoma.

1. Host responses to Epstein-Barr virus and cytomegalovirus infection in leprosy.

2. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

3. Some observations on complement-fixing antibodies to the EB virus.

Review 4. The EB virus in relation to infectious mononucleosis.

5. Two different complement fixing antigens found in the Burkitt lymphoma cell cultures. Brief report.

6. Antibodies to Epstein-Barr virus in a Burkitt's lymphoma cell line in Taiwan monkeys (Macaca cyclopis).

7. Serological response of the EBV antibodies in pediatric cases of infectious mononucleosis and in their contacts.

8. Lymphoma and glandular fever.

Review 9. Infectious mononucleosis: current status of candidate virus.

10. Viruses detected in cells explanted into tissue culture from naturally occurring malignant lymphoma in rhesus monkeys.